«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

25卷

期数:

2019年04期

页码:

359-362

栏目:

临床医学

出版日期:

2019-07-20

文章信息/Info

Title:

Serum IL-17 and IL-35 levels in patients with systemic lupus erythematosus and their correlations with renal damage

文章编号:

1006-8147(2019)04-0359-04

作者:

赵 冕; 朱桂晋; 周 蕾

（天津医科大学总医院风湿免疫科，天津300052）

Author(s):

ZHAO Mian; ZHU Gui-jin; ZHOU Lei

(Department of Rheumatology and Immundogy, General Hospital, Tianjin Medical University, Tianjin 300052, China)

关键词:

白介素（IL）-17; IL-35; 红斑狼疮; 系统性; 狼疮肾炎

Keywords:

IL-17; IL-35; lupus erythematosus;  systemic; lupus nephritis

分类号:

R593.24+1

DOI:

-

文献标志码:

A

摘要:

目的：探讨白介素（IL）-17和IL-35在系统性红斑狼疮（SLE）中的作用及其与肾损害的关系。方法：采用酶联免疫吸附试验（ELISA）检测55例SLE患者和25名健康者血清IL-17和IL-35水平，比较SLE患者与对照者、SLE活动组与SLE非活动组、狼疮肾炎（LN）患者与非LN患者中两种细胞因子的差异，分析SLE患者血清IL-17、IL-35、SLE疾病活动指数（SLEDAI）评分的相关性以及LN患者血清IL-17、IL-35与尿蛋白的相关性。结果：与对照者相比，SLE患者血清IL-17水平升高而IL-35水平降低（P＜0.01），且SLE活动组的血清IL-17水平高于非活动组（P＜0.01），IL-35水平低于非活动组（P＜0.01）。SLE患者血清IL-17水平与SLEDAI评分正相关而IL-35水平与SLEDAI评分负相关，且血清IL-17水平与IL-35水平呈负相关。与非LN患者比较，LN患者的血清IL-17水平升高而IL-35水平减低（P＜0.05），且LN患者尿蛋白定量（24 h）与血清IL-17水平正相关，与IL-35水平负相关。结论：IL-17和IL-35是一对紧密相关的促炎/抗炎细胞因子，血清IL-17水平升高、IL-35水平下降，两者的平衡失调，参与了SLE的疾病发生及其肾脏损伤过程。

Abstract:

Objective: To investigate the serum IL-17 and IL-35 levels in patients with systemic lupus erythematosus(SLE), explore the effect of IL-17 and IL-35 on the pathogenesis of SLE and their relationship with renal damage. Methods: Serum IL-17 and IL-35 levels were quantified using ELISA in 55 patients with SLE and 25 healthy controls, then the levels were compared between SLE patients and healthy controls, active SLE patients and inactive SLE patients, and SLE patients with nephritis and without nephritis, the correlations among serum IL-17, IL-35 and SLEDAI scores in SLE patients were analyzed, and the relationship of serum IL-17 and IL-35 levels with 24-h proteinuria were also analyzed in lupus nephritis(LN) patients. Results: Serum IL-17 levels were significantly higher and IL-35 levels were significantly lower (P＜0.01) in patients with SLE compared with healthy controls.And compared with inactive SLE patients, active SLE patients had higher serum IL-17 levels(P＜0.01) and serum IL-35 levels were decreased in active SLE patients(P＜0.01). A positive correlation was observed between serum IL-17 levels and SLEDAI scores and IL-35 levels were negatively correlated with SLEDAI scores in SLE patients. Furthermore, the expression of IL-17 and IL-35 were negatively correlated with each other. Compared with SLE patients without nephritis, serum IL-17 levels were significantly higher and IL-35 levels were decreased in lupus nephritis(LN) patients(P＜0.05).Moreover, 24-h proteinuria was positively correlated with serum IL-17 levels and negatively with IL-35 levels in LN patients. Conclusion: IL-17 has strong proinflammatory effects and IL-35 is identified as anti-inflammatory cytokines and they are strongly associated with each other, serum IL-17 levels increase and IL-35 levels decrease in SLE patients, and the imbalance between IL-17 and IL-35 may be involved in pathogenesis of SLE and renal damage.

参考文献/References:

[1] Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995,155(3):1151
[2] Harrington L E, Hatton R D, Mangan P R, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol, 2005,6(11):1123
[3] Yang J, Chu Y, Yang X, et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus[J]. Arthritis Rheum, 2009, 60(5):1472
[4] Hochberg M C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997,40(9):1725
[5] Seshan S V, Jennette J C. Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications[J]. Arch Pathol Lab Med, 2009,133(2):233
[6] Bombardier C, Gladman D D, Urowitz M B, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE[J]. Arthritis Rheum, 1992,35(6):630
[7] Nishihara M, Ogura H, Ueda N, et al. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state[J]. Int Immunol, 2007,19(6):695
[8] Segura E, Touzot M, Bohineust A, et al. Human inflammatory dendritic cells induce Th17 cell differentiation[J]. Immunity, 2013,38(2):336
[9] Huang G, Wang Y, Chi H. Regulation of TH17 cell differentiation by innate immune signals[J]. Cell Mol Immunol, 2012,9(4):287
[10] Burgler S, Mantel P Y, Bassin C, et al. RORC2 is involved in T cell polarization through interaction with the FOXP3 promoter[J]. J Immunol, 2010,184(11):6161
[11] 谢梦晓. IL-6和TNF-α经NF-κB-miR-34a/miR-31-Foxp3信号轴导致Treg/Th17细胞失衡[D]. 江苏大学免疫学, 2016
[12] Hsu H C, Yang P, Wang J, et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice[J]. Nat Immunol, 2008,9(2):166
[13] Garrett-Sinha L A, John S, Gaffen S L. IL-17 and the Th17 lineage in systemic lupus erythematosus[J]. Curr Opin Rheumatol, 2008, 20(5):519
[14] Chen D Y, Chen Y M, Wen M C, et al. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis[J]. Lupus, 2012,21(13):1385
[15] He D, Liu M, Liu B. Interleukin-35 as a new biomarker of renal involvement in lupus nephritis patients[J]. Tohoku J Exp Med, 2018, 244(4):263
[16] Turner J E, Paust H J, Steinmetz O M, et al. The Th17 immune response in renal inflammation[J]. Kidney Int, 2010,77(12):1070
[17] Amarilyo G, Lourenco E V, Shi F D, et al. IL-17 promotes murine lupus[J]. J Immunol, 2014,193(2):540
[18] Cai Z, Wong C K, Dong J, et al. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice[J]. Clin Exp Immunol, 2015,181(2):253
[19] Ouyang H, Shi Y B, Liu Z C, et al. Decreased interleukin 35 and CD4+EBI3+T cells in patients with active systemic lupus erythematosus[J]. Am J Med Sci, 2014,348(2):156

相似文献/References:

备注/Memo

备注/Memo:

作者简介 赵冕（1989-），男，硕士在读，研究方向：风湿病学；通信作者：周蕾，E-mail：yizhe1234@126.com。

常用功能

更新日期/Last Update: 2019-08-28